Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Article Type
Date
Availability
1-4 of 4
Keywords: osteoprotegerin
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2022) 136 (5): 379–382.
Published: 11 March 2022
...Nhat-Tu Le; Elizabeth A. Olmsted-Davis; Jun-ichi Abe Osteoprotegerin (OPG), also known as osteoclastogenesis inhibitory factor or tumor necrosis factor receptor superfamily member 11B, is well known as a modulator of bone remodeling. The contribution of OPG to cardiovascular disease (CVD) has been...
Articles
Osteoprotegerin regulates vascular function through syndecan-1 and NADPH oxidase-derived reactive oxygen species
Available to PurchaseRhéure Alves-Lopes, Karla Bianca Neves, Anastasiya Strembitska, Adam P. Harvey, Katie Y. Harvey, Hiba Yusuf, Susan Haniford, Ross T. Hepburn, Jennifer Dyet, Wendy Beattie, Laura Haddow, John McAbney, Delyth Graham, Augusto C. Montezano
Journal:
Clinical Science
Clin Sci (Lond) (2021) 135 (20): 2429–2444.
Published: 28 October 2021
...Rhéure Alves-Lopes; Karla Bianca Neves; Anastasiya Strembitska; Adam P. Harvey; Katie Y. Harvey; Hiba Yusuf; Susan Haniford; Ross T. Hepburn; Jennifer Dyet; Wendy Beattie; Laura Haddow; John McAbney; Delyth Graham; Augusto C. Montezano Osteogenic factors, such as osteoprotegerin (OPG...
Includes: Supplementary data
Articles
Diabetes confers in vitro calcific potential on serum which associates with in vivo vascular calcification
Open Access
Journal:
Clinical Science
Clin Sci (Lond) (2017) 131 (10): 991–1000.
Published: 09 May 2017
... 0.70: P =0.009). The distribution of CP was bimodal around a cutoff of 100 nmoles of Ca 2+ protein mg −1 , with a higher proportion of Type 2 diabetes subjects with in vivo calcification (T2DM+) sera above the cutoff value. This group also showed elevated levels of osteoprotegerin (OPG) and matrix Gla...
Articles
Relationship of serum osteoprotegerin levels with coronary artery disease severity, left ventricular hypertrophy and C-reactive protein
Available to PurchaseEun-Jung RHEE, Won-Young LEE, Se-Yeon KIM, Byung-Jin KIM, Ki-Chul SUNG, Bum-Su KIM, Jin-Ho KANG, Ki-Won OH, Eun-Sook OH, Ki-Hyun BAEK, Moo-Il KANG, Hee-Yeon WOO, Hyo-Soon PARK, Sun-Woo KIM, Man-Ho LEE, Jung-Roe PARK
Journal:
Clinical Science
Clin Sci (Lond) (2005) 108 (3): 237–243.
Published: 18 February 2005
...Eun-Jung RHEE; Won-Young LEE; Se-Yeon KIM; Byung-Jin KIM; Ki-Chul SUNG; Bum-Su KIM; Jin-Ho KANG; Ki-Won OH; Eun-Sook OH; Ki-Hyun BAEK; Moo-Il KANG; Hee-Yeon WOO; Hyo-Soon PARK; Sun-Woo KIM; Man-Ho LEE; Jung-Roe PARK OPG (osteoprotegerin) is an inhibitor of osteoclastogenesis and recent work...
